e-learning
resources
Paris 2018
Monday, 17.09.2018
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial lung diseases misdiagnosis: a Healthcare Improvement Science (HIS) approach
R. Crisan-Dabija (Iasi, Romania), T. Mihaescu (Iasi, Romania)
Source:
International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session:
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session type:
Thematic Poster
Number:
2983
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Crisan-Dabija (Iasi, Romania), T. Mihaescu (Iasi, Romania). Interstitial lung diseases misdiagnosis: a Healthcare Improvement Science (HIS) approach. 2983
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Healthcare utilisation in childhood interstitial lung diseases: Analysis of chILD-EU registry data
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016
Healthcare resource utilisation (HRU) in the Asthma Salford Lung Study (SLS asthma)
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Research highlights from the 2018 ERS International Congress: interstitial lung diseases
Source: ERJ Open Res, 5 (1) 00215-2018; 10.1183/23120541.00215-2018
Year: 2019
The Electronic Asthma Management System (eAMS) improves primary care asthma management
Source: Eur Respir J, 53 (4) 1802241; 10.1183/13993003.02241-2018
Year: 2019
Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey
Source: International Congress 2016 – IPF clinical
Year: 2016
Imaging of empyema (EMP) in children: How bedside ultrasonography (US) impact on clinical practice?
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Inspiration: An assistance program for idiopathic pulmonary fibrosis patients on pirfenidone
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014
Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR)
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
Quality of life in interstitial lung disease: Utility of the Kings brief interstitial lung disease questionairre at baseline
Source: International Congress 2015 – New insights into IIPs
Year: 2015
A service evaluation of the accuracy of the Gold Standard Framework Proactive Indicator Guidance (GSF PIG) in predicting 12 month mortality in patietns with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD).
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014
Interim analysis of the EXCITING-ILD registry
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017
Year: 2018
Sarcoidosis in the UK: Insights from the BTS interstitial lung disease registry
Source: International Congress 2016 – Sarcoidosis
Year: 2016
The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research
Source: Eur Respir J, 52 (5) 1801671; 10.1183/13993003.01671-2018
Year: 2018
International scientific communications in the field of chronic bronchitis and pulmonary emphysema
Source: International Congress 2014 – Medical education: web and internet
Year: 2014
Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Risk of cancer incidence in patient with idiopathic pulmonary fibrosis: An analysis of the National Health Insurance Service database of Korea
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Quality of pneumonia assessment tools for community acquired pneumonia in Korea; From the Health Insurance Review and Assessment (HIRA) database
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept